The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

Day case TAVI: is this a reality?

EuroIntervention 2017;13:907-909. DOI: 10.4244/EIJV13I8A135

Imperial College Healthcare Trust and Imperial College London, London, United Kingdom


Transcatheter aortic valve implantation (TAVI) has transformed the treatment of high-risk patients with severe aortic stenosis, with over a hundred thousand procedures performed worldwide since the first implant in 20021. Initial procedures were commonly associated with severe periprocedural complications and protracted hospital stays; however, device improvements and greater clinician experience have led to reductions in procedural times, and in the incidence and severity of complications. Reductions in sheath sizes and improved delivery systems have enabled safer device transfer via femoral access. Preoperatively, computed tomography scanning is now used routinely for access-site planning, valve sizing and coronary artery disease screening, thereby ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
ESC 2017 – Maturity and outreach